High-level cytoplasmic claudin 3 expression is an independent predictor of poor survival in triple-negative breast cancer

BACKGROUND: The subtype of claudin-low breast cancer can be reliably determined only by gene-expression profiling. Attempts have been made to develop immunohistochemical surrogates, which nearly always focus on membranous claudin expression. METHODS: We assessed the immunohistochemical expression of...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:BMC Cancer
Hauptverfasser: Jääskeläinen, Anniina, Soini, Ylermi, Jukkola-Vuorinen, Arja, Auvinen, Päivi, Haapasaari, Kirsi-Maria, Karihtala, Peeter
Format: Artigo
Sprache:Inglês
Veröffentlicht: BioMed Central 2018
Schlagworte:
Research Article
Online Zugang:https://ncbi.nlm.nih.gov/pmc/articles/PMC6389078/
https://ncbi.nlm.nih.gov/pubmed/29482498
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12885-018-4141-z
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!

Ähnliche Einträge